What is going on..., page-2

Yes I also think it's weird that we didn't get updates on Vitiligo or XP or adolescent trial progress. I don't think the stock price is low because of refusal to mention Disc or short sellers, but I think not mentioning them might be due to the questions it raises on the need to do a share buyback. The newsletter showed just how effective a share buyback would be because it openly said one single institution buying a lot of shares in one month was enough to raise the share price to over $40 (sep 21). Of course shorters walked the price back down after this, but it clearly demonstrates my thesis of how effective a $20 - $30 Million share buyback would be if done right. Saying it is not possible due to payors, while running Michelin catered Soirees and grants of shares and top notch profits and remuneration are happening, shows that it is obviously possible bc the only argument against is quite a questionable one. A shorting assisted takeover is always another option I guess but I had never really considered it could be a private takeover as you mention. Why do you say Wolgen is part of the play to hold the stock at these low levels? It is pretty clearly undervalued these days when most analysts have price targets in the mid $20s and some up to $50. It's definitely going to be an interesting year.

All IMO DYOR